Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia. Pediatr Infect Dis J. 2002; 21(9): 810-5.Harboe ZB, Valentiner-Branth P, Benfield TL, et al. Effectiveness of hep- tavalent pneumococcal conjugate vac...
A decision analysis of the cost-effectiveness of hepatitis A vaccination for adults with hepatitis C was conducted. No vaccination strategy is cost-effective... MK Chapko,HS Yee,A Monto,... - 《Vaccine》 被引量: 8发表: 2010年 Cost-effectiveness of hepatitis A vaccination for adults in Belgi...
Post-exposure prophylaxis with hepatitis B vaccine (HepB) alone is highly effective in preventing perinatal hepatitis B virus (HBV) transmission and the Wo... L Zhang,S Ko,J Lv,... - 《Human Vaccines》 被引量: 1发表: 2014年 Cost-effectiveness of antiviral prophylaxis during pregnancy for ...
The scientific primary objective of DRIVE project is to calculate vaccine effectiveness (VE) for any influenza vaccine and brand-specific VE, against any influenza, by type and subtype/lineage. To this end, age- and setting-stratified pooled IVE estimates were calculated from test-negative design...
The model does not involve the isolation of asymptomatic subjects because it is less likely to occur in the context of a university population. Since the vaccinated and boosted individuals can still get infected, we regard them as susceptible but with lower infection rates (i.e. vaccine break...
Finally, we assessed the efficiency of each strategy and we compared the cost-effectiveness ratios with a 'no vaccination' strategy. Effectiveness indi- cators took into account not only the immediate results of immunization (vaccine doses used, vaccinated chil- dren) but also the impact on ...
Respiratory Syncytial Virus Inhibits Ciliagenesis in Differentiated Normal Human Bronchial Epithelial Cells: Effectiveness of N-Acetylcysteine Manuel Mata1,2*, Irene Sarrion1, Miguel Armengot3,4, Carmen Carda3, Isidoro Martinez2,5, Jose A. Melero2,6, Julio Cortijo1,2,3 1 R...
The trial in Finland (FinOM) was a randomized, double-masked trial in which 1662 healthy Finnish infants received either PREVENAR or a control vaccine (hepatitis B vaccine [Hep B]), given according to the same schedule as in Results The per protocol, vaccine efficacy values for PREVENAR agains...
(Hib); by age 4 months: 2 Hep B, 2 DTP, 2 poliovirus, 2 Hib; by age 6 months: 2 Hep B, 3 DTP, 2 poliovirus, 3 Hib; by age 12 months: 2 Hep B, 3 DTP, 2 poliovirus, 3 Hib; by age 24 months: 3 Hep B, 4 DTP, 3 poliovirus, 3 Hib, 1 measles- containing vaccine. ...
A safe and effective vaccine for HBV has been available since 1982, whereas no vaccine for HCV exists [7]. Treatment options are advancing rapidly, and several new antiviral drugs have become available in the past decade. Evidence is accumulating that these therapies provide a cost-effective mean...